ESR1 and breast cancer: There is a constant search for new approaches to treating breast cancer (BC) due to its prevalence and rapid development of tumor resistance, which is characteristic of triple-negative BC (in which there is an absence of estrogen receptor, progesterone receptor, and receptor tyrosine-protein kinase gene expression).